RITIS 3.0® EPHEMERA PHARMA® Cream 50g

RITIS 3.0® EPHEMERA PHARMA® Cream - Medical Device

Product to be applied on damaged skin.
The medical device is intended for long-term or in-patient patients with non-ulcerative erythematous areas, blisters with initial ulceration or lesions involving the epidermis and the superficial dermis. The device is intended for use by patients with symptoms such as erythema reversible from pressure or lesions affecting the epidermis and dermis such as vascular lesions, vasculitic lesions, bedsores and burns.
Perform two applications a day on the areas to be treated.
It does not contain perfume, parabens.

How to use

Open the dispenser cap. Compress the tube until the desired dose of product comes out; to prevent contamination, avoid direct contact of the tube with the area to be treated.
Close the dispenser cap. Gently spread on the area to be treated a quantity of product such as to ensure, after absorption, a uniform residual veil on the whole treated area.

Components

Aqua, ciclopentasyloxane, C12-20 acid PEG-8 ester, colostrum extract, dimethicone, Prunus amygdalus dulcis oil, alluminium starch octenylsuccinate, titanium dioxide anatase, cetyl alcohol, PEG-90 stearate, glyceryl stearate, stearic acid, potassium sorbate, sodiumbenzoate tocopheryl acetate, panthenol, xanthan gum, diazolidinylurea, phenoxyethanol, disodium EDTA, glucose, xanthan gum, caprylyl glicol, ethylhexylglycerin, Chondrus crispus powder.

Warnings

Do not use the product in case of ascertained hypersensitivity to one of the components.
Do not use the product if the packaging is not intact or if it is open.
Do not use beyond the expiration date.
Avoid contact with eyes.
Do not swallow.
Apply in hygienic conditions (clean and / or protected hands).
Avoid direct contact of the dispenser with the area to be treated.
In case of allergic skin reactions in the treated areas, stop the treatment as a precaution and consult your doctor.
Inform your doctor if you observe a worsening of the pathological state or if after 30 days of use there is no improvement in the pathological state.
Seek medical advice before use during pregnancy, lactation or concomitance with drugs.
After 30 days, stop the treatment for a period of 2 weeks.
It is not recommended for pediatric use.

storage

Store at room temperature, away from sources of light and heat. Keep out of sight and reach of children.
Validity for intact packaging: 36 months.

Format

50g tube.
Cod. FT.CE.15